Summary of potential E-selLs expressed on CD34pos-BM cells identified by MS
Description . | Probability . | Coverage of peptide sequence, % . | Peptide sequence . |
---|---|---|---|
CD34 | 1 | 9.6 | LGILDFTEQDVASHQSYSQK,TSSC[160]AEFKK,LGILDFTEQDVASHQSYSQK, TSSC[160]AEFK, DRGEGLAR |
Galectin-9B | .9997 | 7.3 | FEDGGYVVC[160]NTR SIILSGTVLPSAQR |
Galectin-9 | .9998 | 7 | FEDGGYVVC[160]NTR |
CD44/HCELL | 1 | 5.8 | LVINSGNGAVEDR SQEM[147]VHLVNK NLQNVDM[147]K |
Galectin-3 | 1 | 5.6 | ASHEEVEGLVEK LADGGATNQGR AVDTWSWGER |
CD43 | .9996 | 4.5 | TGALVLSR |
Integrin β-2 | 1 | 3.9 | TTEGC[160]LNPR YNGQVC[160]GGPGR SSQELEGSC[160]R |
PSGL-1 | .9907 | 2.2 | SPGLTPEPR |
Fms-related tyrosine kinase 3 ligand cytokine receptor | .9977 | 1.6 | EMDLGLLSPQAQVEDS |
Integrin α-L | .9337 | 0.9 | HGGLSPQPSQR |
Description . | Probability . | Coverage of peptide sequence, % . | Peptide sequence . |
---|---|---|---|
CD34 | 1 | 9.6 | LGILDFTEQDVASHQSYSQK,TSSC[160]AEFKK,LGILDFTEQDVASHQSYSQK, TSSC[160]AEFK, DRGEGLAR |
Galectin-9B | .9997 | 7.3 | FEDGGYVVC[160]NTR SIILSGTVLPSAQR |
Galectin-9 | .9998 | 7 | FEDGGYVVC[160]NTR |
CD44/HCELL | 1 | 5.8 | LVINSGNGAVEDR SQEM[147]VHLVNK NLQNVDM[147]K |
Galectin-3 | 1 | 5.6 | ASHEEVEGLVEK LADGGATNQGR AVDTWSWGER |
CD43 | .9996 | 4.5 | TGALVLSR |
Integrin β-2 | 1 | 3.9 | TTEGC[160]LNPR YNGQVC[160]GGPGR SSQELEGSC[160]R |
PSGL-1 | .9907 | 2.2 | SPGLTPEPR |
Fms-related tyrosine kinase 3 ligand cytokine receptor | .9977 | 1.6 | EMDLGLLSPQAQVEDS |
Integrin α-L | .9337 | 0.9 | HGGLSPQPSQR |